The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Larger Will The Sterile Compounding Pharmacies Market Become By 2030 Compared To 2026?
The sterile compounding pharmacies market has seen substantial growth recently. It is projected to expand from $5.62 billion in 2025 to $5.98 billion in 2026, at a compound annual growth rate (CAGR) of 6.5%. This market’s past expansion is due to an increase in injectable therapies, the demand from hospital pharmacies, the enforcement of regulations, the necessity for oncology drug compounding, and specific specialty medication needs.
The sterile compounding pharmacies market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $7.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the forecast period include the rise in biologic drugs, customized injectable treatments, limitations in hospital capacity, increased adoption of automation, and evolving regulatory standards. Key trends shaping the market during this period involve the outsourcing of sterile compounding activities, cutting-edge cleanroom technologies, the integration of automation into compounding workflows, robust batch-level traceability, and investments spurred by compliance requirements.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12073&type=smp
What Influential Factors Are Boosting The Sterile Compounding Pharmacies Market Demand?
The growing need for personalized medicine is anticipated to drive the expansion of the sterile compounding pharmacies market in the future. Personalized medicine involves medical approaches that leverage an individual’s genetic or protein data to prevent, diagnose, or treat illnesses. These pharmacies are crucial for delivering tailored medications to patients within a sterile setting, ensuring customized treatment plans that match individual requirements and mitigate adverse reactions to specific dosages or drug formulations. This approach enhances treatment effectiveness, boosts patient satisfaction, and improves compliance with therapy. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA granted approval to 16 novel personalized treatments for rare disease patients in 2023, which was a notable rise from the six approvals recorded in 2022. Consequently, the rising demand for personalized medicine is fueling the sterile compounding pharmacies market.
What Are The Core Segment Classifications In The Sterile Compounding Pharmacies Market?
The sterile compounding pharmacies market covered in this report is segmented –
1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary
Subsegments:
1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels
What Trends Are Shaping The Sterile Compounding Pharmacies Market Structure?
Leading companies operating within the stemcell/cord blood banking market are developing services for peripheral blood stem cell processing and storage to gain a competitive edge. This process, known as peripheral blood stem cell processing and storage, encompasses the collection, preparation, testing, and cryopreservation of haematopoietic stem cells (HSCs) derived from a patient’s peripheral blood. As an illustration, in February 2023, Cordlife Group Limited, a Singapore-based healthcare enterprise, launched a new peripheral blood stem cell (PBSC) processing and storage service in Singapore. This offering is designed to support patients who require haematopoietic stem cell transplantation for treating various blood-related conditions, including leukemia, myeloma, and lymphoma. Cordlife’s partnership with the Centre for Clinical Haematology (CFCH) facilitates eligible patients undergoing stem cell mobilization and harvesting, with Cordlife then managing the subsequent processing, testing, and cryopreservation of the PBSCs. The aim of this new service is to enhance treatment outcomes for individuals needing haematopoietic stem cell transplants and to expand Cordlife’s array of banking services available in Singapore.
Who Are The Firms Contributing To The Sterile Compounding Pharmacies Market Ecosystem?
Major companies operating in the sterile compounding pharmacies market are B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter’s House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.
Access The Complete Sterile Compounding Pharmacies Market Report:
What Is The Largest Regional Market In The Sterile Compounding Pharmacies Market?
North America was the dominant region in the sterile compounding pharmacies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Sterile Compounding Pharmacies Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12073&type=smp
Browse Through More Reports Similar to the Global Sterile Compounding Pharmacies Market 2026, By The Business Research Company
Sterile Medical Packaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/sterile-medical-packaging-global-market-report
Pharmacies And Drug Stores Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report
Depyrogenated Sterile Empty Vials Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model